Sidharth Mehta, MD
About Sidharth Mehta, MD
Sidharth Mehta, MD, is a Senior Associate in Biotechnology Equity Research at Jefferies, with a background in healthcare leadership and innovation, and extensive experience in the medical and biotechnology fields.
Title
Sidharth Mehta, MD, is a Senior Associate in Biotechnology Equity Research. He currently holds this position at Jefferies since 2021 and is based in Miami, Florida, United States.
Education and Expertise
Sidharth Mehta holds a Doctor of Medicine (MD) from St. George's University, where he studied from 2013 to 2017. Additionally, he earned a Master of Science (MS) in Biomedical Sciences from Rutgers Robert Wood Johnson Medical School in 2011. He also holds a Bachelor of Arts (BA) in Economics from Villanova University, where he studied from 2005 to 2009. Mehta has expertise in biotechnology equity research with a focus on the healthcare sector, combined with strong skills in product management and a history of working in hospital and healthcare industries.
Background
Sidharth Mehta has a multifaceted background in the medical and healthcare industries. He has held roles such as Vice President, Associate Medical Director at Entrée Health in 2021, Vice President, Associate Director, Business Development at Omnicom Health Group from 2020 to 2021, and General Surgery Resident at Rutgers New Jersey Medical School from 2018 to 2019. He has also been a Resident Physician in General Surgery at The Brody School of Medicine at East Carolina University and participated in Healthcare Leadership and Innovation at Jersey City Medical Center - Barnabas Health.
Achievements and Roles
Sidharth Mehta has held significant roles in various organizations, exemplifying his leadership in the healthcare field. He is the Founder and CEO of Capital Health Ventures, starting his tenure in this role in 2019. Additionally, he served as a Biomedical Ethics Committee Member at Hackensack University Medical Center from 2015 to 2017. Mehta has a demonstrated capability in utilizing Microsoft Excel, Office, and PowerPoint for research purposes, which further underscores his proficiency in biotechnology equity research and product management within the healthcare sector.